Thyrotropin-releasing hormone receptor: Its partial purification from bovine anterior pituitary gland and its close association with adenyl cyclase  by Poirier, Guy et al.
Volume 20, number 3 FEBS LETTERS February 1912 
THYROTROPIN-RELEASING HORMONE RECEPTOR: ITS PARTIAL 
PURIFICATION FROM BOVINE ANTERIOR PITUITARY GLAND 
AND ITS CLOSE ASSOCIATION WITH ADENYL CYCLASE” 
Guy POIRIER, Fernand LABRIE**, 
Nicholas BARDEN*** and Simon LEMAIRE**** 
Laboratory of Molecular Endocrinology, 
Faculty of Medicine, Lava1 University, Quebec 10, Canada 
Received 13 December 1971 
1. Introduction 
A contribution of major interest in the field of 
neuroendocrinology has been the first and recent 
elucidation of the structure of one of the hypo- 
thalamic releasing hormones. The structure of thyro- 
tropin-releasing hormone (TRH), the hormone which 
controls the activity of the thyrotropin-secreting 
cells in the anterior pituitary gland, has in fact been 
shown to be L-pyroglutamyl-L-histidyl-L-proline 
amide [ 1,2] . 
Since there is strong evidence for a role of adeno- 
sine 3’,5’-monophosphate (cyclic AMP) as mediator 
of the action of the hypothalamic releasing hormones 
[3-lo], and for a primary action of some polypep- 
tide hormones by binding to a receptor closely re- 
lated to adenyl cyclase, [I l-141 , it seemed impor- 
tant to attempt a purification of the receptor for 
TRH and to investigate the possibility of a close 
correlation of the subcellular distributions of 3H- 
TRH binding and of adenyl cyclase activity. 
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2. Materials and methods 
Bovine anterior pituitaries were collected in local 
slaughterhouses and immediately brought to the 
laboratory in ice-cold Krebs-Ringer bicarbonate 
buffer, pH 7.4, containing 11 mM D-glucose. Plasma 
membranes were isolated by our modification of 
Neville’s technique originally designed for the puri- 
fication of plasma membranes from rat liver [ 1.51. 
All procedures were carried out at O-4”. Briefly, 
anterior pituitaries in 5 vol of buffer D (0.001 M 
NaHC03 -0.005 M mercaptoethanol) were treated 
for 30 set at half-maximal speed in a Waring Blendor 
before homogenization with 15 strokes of a Glenco 
teflon-glass homogenizer having a clearance of 0.125 
mm. 25 ml of buffer D were then added per g of 
original pituitary tissue and the dilute homogenate 
was stirred for 2 min at low speed before filtration 
through 4 layers of cheesecloth and centrifugation 
of the filtrate at 2,000g for 30 min. The supematant 
was removed by aspiration and discarded. The jelly- 
like pellet was resuspended with 2 strokes of the 
pestle in a loose-fitting homogenizer after addition 
of 4 ml of buffer D per g of pituitary tissue. The 
suspension was centrifuged in 50 ml conical tubes 
at 1,220 g for 20 min. The 1,220 g supernatant was 
aspirated and kept while the pellet was resuspended 
in 3 ml of buffer D per g of tissue, and the centri- 
fugation at 1,220 g repeated once. The pellet was 
discarded and the 1,220 g supernatants pooled. 
To obtain a first separation of plasma membranes 
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from the secretory granules also present in the 1,220 
g supernatant, the fraction was sedimented at 30,000 
g for 30 min. The supernatant was carefully aspirated 
and discarded, while the brownish top layer of the 
pellet, containing mostly membranes, was carefully 
removed for further purification. The white bottom 
layer of the 30,OOOg pellet contained almost exclu- 
sively secretory granules. The brownish top layer 
was resuspended in 47.5% (w/v) sucrose in water 
(d = 1.18) and centrifuged at 95,OOOg for 2.5 hr in 
a step-sucrose gradient containing layers of densities 
1.14, 1.16, 1.18, 1.20 and 1.22. As shown by elec- 
tron microscopy, enzyme markers, and the protein 
pattern obtained by polyacrylamide gel electropho- 
resis (G. Poirier, F. Labrie, S. Lemaire, G. Pelletier 
and A. Lemay, unpublished), the material sediment- 
ing at the interface 1.14-l. 16 consisted of pure plas- 
ma membranes, while the material accumulating at 
the interfaces of densities 1.18-l .20 and 1.20-l .22 
consisted of rough microsomes. The secretory granules 
were quantitatively recovered in the pellet. This rather 
simple technique, when applied to anterior pituitary 
tissue, yields simultaneously plasma membranes, 
rough microsomes and secretory granules. These 3 
fractions are of great interest for studies of the mech- 
anism of action of the hypothalamic releasing hor- 
mones and of adenosine 3’,5’-cyclic monophosphate 
in the anterior pituitary gland. 
3. Results and discussion 
3.1. Binding of ‘H-TRH to adenohypophyseal plasma 
membranes 
Plasma membranes isolated at the interface of 
sucrose densities 1.14 and 1.16 show a 40-fold in- 
crease of ‘H-TRH binding as compared to the total 
adenohypophyseal homogenate (fig. 1). The fraction 
sedimenting at 1.16- 1.18 consists of plasma mem- 
branes contaminated to a variable extent by saccules 
originating probably from the Golgi complex and 
shows binding values intermediate between those of 
pure plasma membranes and of the rough microsomes 
which sediment at the interfaces 1.18- 1.20 and 
1.20- 1.22. No binding can be measured in the pellet 
consisting of pure secretory granules. 
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Fig. 1. Distribution of ‘H-TRH binding and fluoride-stimu- 
lated adenyl cyclase activity in adenohypophyseal membrane 
fractions. Membrane fractions were prepared as described in 
the text. Measurements of ‘H-TRH binding were performed 
as described [ 161. In the standard assay, 50 Gg of membrane 
protein were incubated in a final volume of 5.5 ~1 in buffer F 
(0.020 M sodium phosphate, pH 7.35-0.0075 M KCI- 
0.002 M MgClz) containing 5.0 X lo-* M ‘H-TRH (55,000 
cpm) at 0” for 40 min. The reaction was stopped by the addi- 
tion of 1 .O ml of ice-cold buffer F and the medium imme- 
diately filtered with gentle suction through a Millipore filter 
with 3 successive washes with 2 ml of ice-cold buffer. After 
drying at 60” for 30 min, 10 ml of PPO-POPOP-toluene 
scintillation fluid were added and the radioactivity measured 
in a Packard liquid scintillation spectrometer. AlI assays 
were done in triplicate. Adenyl cyclase activity was deter- 
mined according to Krishna, Weiss and Brodie [ 171 The in- 
cubation was carried out for 10 min at 37” in medium con- 
taining 40 mM Tris-HCI, pH 7.4, 3.3 mM MgS04, 3.0 mM 
adenosine 3’,5’-monophosphate, 10 mM NaF and 1 mM 
=H-ATP. 
It can also be seen in fig. 1 that the specific ac- 
tivity of adenyl cyclase measured in the presence 
of 10 mM NaF shows a pattern of distribution 
similar to the binding of ‘H-TRH. Maximal adenyl 
cyclase activity is in fact found in the plasma mem- 
brane fraction. The activity decreases progressively 
in the material sedimenting at higher densities in the 
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Table 1 
Subcelhtlar distribution of 3H-TRH binding and adenyl cyclase activity 
in anterior pituitary gland. 
February 1972 
Fractions Adenyl cyclase activity TRH binding 
(pmoles of cyclic AMP (femtomoles of 3H-TRH 
formed/mg proteinlmin) bound/mg protein) 
Total homogenate 70.6 f. 17 15.7 * 0.1 
Nuclei 113.6 f 15.6 110.0 f 7.1 
Mitochondria 64.4 + 7.3 65.6 f 0.4 
15 K (microsomes + 
secretory granules) 83.8 ? 5.3 84.5 f 0.7 
200,000 g Supernatant 7.9 f 1.5 6.7 f 0.6 
Total microsomes 178.5 * 13.0 207.5 f 9.9 
Rough microsomes 68.5 f 3.1 46.1 + 3.2 
Smooth membranes 375.1 f 12.6 526.0 f 25.2 
Subcellular fractions were prepared as described [S] . Measurements of 3H-TRH binding and of adenyl cyclase activity were 
carried out as described in fig. 1. 
sucrose gradient. A lo- to 15fold purification of 
adenyl cyclase specific activity is usually observed in 
the plasma membrane fraction as compared to the 
total cell homogenate. Although 3H-TRH binding 
and fluoride-stimulated adenyl cyclase activity are 
located almost exclusively in plasma membranes, the 
degree of purification of enzymatic activity is con- 
siderably lower than that of hormone binding. This 
finding is likely to be accounted for by the relative 
instability of the adenyl cyclase during preparation 
of the plasma membranes. 
3.2. Subcellular distribution of 3H-TRH binding and 
adenyl cyche activity 
Table 1 illustrates that both 3H-TRH binding and 
adenyl cyclase activity are found almost exclusively 
in the particulate fractions, negligible amounts of 
either activity being found in the 200,000 g super- 
natant fraction. As previously observed for the mem- 
brane fractions separated by step-sucrose gradient 
(fig. l), a good correlation exists in all subcellular 
fractions between TRH binding and adenyl cyclase 
activity. The appreciable level of hormone binding 
in the particulate fractions (nuclei, mitochondria 
and 15 K) could be accounted for by some contam- 
ination of these fractions by plasma membranes. 
Total microsomes contain high levels of both adenyl 
cyclase activity and TRH binding. Further purifi- 
cation of this fraction shows that both activities 
can be almost quantitatively recovered in smooth 
membranes showing the morphological and en- 
zymatic properties of plasma membranes. 
We have recently studied the properties of the 
interaction of 3H-TRH with its receptor in adeno- 
hypophyseal plasma membranes [ 161 and have 
shown that the neurohormone interacts according 
to a bimolecular process with the cell membrane 
receptor. The interaction is reversible, highly spe- 
cific and has a dissociation constant of about 
3.0 X 1O-8 M. 
Preliminary studies in our laboratory suggest a 
direct interaction of the TRH receptor with adenyl 
cyclase in the plasma membranes of the anterior 
pituitary cell with resulting enhancement of en- 
zymatic activity. The present demonstration of an 
almost exclusive location of the receptor for TRH 
in the plasma membrane which is also the main site 
of the adenyl cyclase in the anterior pituitary cell, 
as well as in the other mammalian tissues studied 
[ 18, 191, suggests trongly that the interaction of 
TRH with plasma membranes is the first step in 
hormone action and that this interaction is likely 
to be in functional relationship with the adenyl 
cyclase. The presented data also provide a means 
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for dissecting the overall action of TRH in the adeno- 
hypophyseal cell by studying the primary action of 
TRH, its interaction with the membrane receptor, 
instead of some later distant consequence of the 
primary TRH-receptor interaction. It could be argued 
that TRH could, in addition to its interaction with 
the plasma membrane, penetrate inside the cell and 
interact with some intracellular structure. However, 
our data on the subcellular distribution of 3H-TRH 
binding (table 1) show that this potential intracellular 
binding could not represent more than a minor com- 
ponent: It should also be mentioned that the results 
which we have obtained so far indicate that binding 
of TRH shares many characteristics with the binding 
of larger peptides such as ACTH [ 12, 131 and glu- 
cagon [ 13, 141 to the plasma membranes of their 
target cells. 
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